58 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery … mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any
8-K
CCCC
C4 Therapeutics Inc
8 Mar 24
Departure of Directors or Certain Officers
4:10pm
”) approved an option repricing, in accordance with the Company’s 2020 Stock Option and Incentive Plan (the “2020 Plan”), which repricing was effected … the repricing, with the original exercise price applicable during the Retention Period, to provide added incentive to retain and motivate the holders
S-8
CCCC
C4 Therapeutics Inc
22 Feb 24
Registration of securities for employees
9:01am
splits, stock dividends or similar transactions.
(2)Consists of 3,023,359 additional shares issuable under the 2020 Stock Option and Incentive Plan … , which represents the automatic annual increase to the number of shares available for issuance under the 2020 Stock Option and Incentive Plan effective
S-8
fgcx cni0t1xcqnnen
22 Feb 24
Registration of securities for employees
9:01am
S-8
EX-5.1
mmpn38
22 Feb 24
Registration of securities for employees
9:01am
8-K
t0hx6i
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
cw9ee
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
8-K
EX-10.2
65wpqgv10uj p91r7dmx
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
sto qr4g7dzsd
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
s8t52kheiuv
18 Apr 23
Preliminary proxy
7:59am